Livzon Pharmaceutical details share repurchase activities for A shares

Livzon Pharmaceutical Group Inc. submitted its Next Day Disclosure Return on September 8, 2025, detailing changes in its issued shares. For its H ordinary shares, the company reported an opening and closing balance of 299,807,117 issued shares (excluding treasury shares) as of September 5, 2025, with no changes noted on September 8, 2025. There were also no treasury shares reported for this class.

For its A ordinary shares, the company's opening and closing balance of issued shares (excluding treasury shares) was 604,293,313 as of September 5, 2025, with no changes on September 8, 2025. However, the report shows a series of A shares repurchased for cancellation, starting from December 25, 2024, and continuing through September 8, 2025. These repurchases involved varying numbers of shares and prices. For instance, on December 25, 2024, 145,700 A shares were repurchased at RMB37.75, representing 0.0157% of existing issued shares. On September 8, 2025, 72,700 A shares were repurchased at an average price of RMB41.26.

The repurchase report for September 8, 2025, specifically highlighted a buyback of 72,700 A shares on the Shenzhen Stock Exchange, with a highest repurchase price of RMB41.64 and a lowest of RMB40.98. The aggregate price paid for these shares was RMB2,999,492. These 72,700 shares are intended for cancellation, bringing the total number of shares repurchased for cancellation to 72,700. The company confirmed that all repurchases were made in accordance with relevant Main Board Rules and domestic rules.